Product Information

RIFABUTIN 150 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $8.0575 per EA under NDC 70954004110. Its NADAC has been published 183 times since May 17, 2023.

FDA first approved this application on Dec 17, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIFABUTIN 150 MG CAPSULE

Rifabutin
$8.0575per EA

Strength

150 mg/1

NDC

70954004110

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIFABUTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA215041

FDA Approved

12/17/2021

TE Code

AB

On Market Since

12/17/2021

Pharmacological Classes

Rifamycin Antimycobacterial
Rifamycins

Price Statistics

The NADAC for RIFABUTIN 150 MG CAPSULE has been published 183 times since May 17, 2023, and over the history we have for it it has declined 25.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.0575 per EA
All-time high$10.7596 (Jun 14, 2023)
All-time low$7.3273 (Jun 19, 2024)
52-week high$9.6009
52-week low$8.0575
Median price$9.3240
Average price$9.3147
Largest weekly change-18.0% (May 22, 2024)
Weeks tracked183
Tracking sinceMay 17, 2023

Price History

1W

0.0%

1M

-1.0%

3M

-5.7%

6M

-14.9%

1Y

-7.7%

3Y

-23.0%

5Y

N/A

All

-25.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Rifabutin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIFABUTIN 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIFABUTIN 150 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $8.0575 per EA (NDC 70954004110), effective Nov 11, 2026.

How has the price of RIFABUTIN 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIFABUTIN 150 MG CAPSULE has declined 25.1%. It has been tracked across 183 weekly CMS publications since May 17, 2023.

What are the highest and lowest recorded NADAC prices for RIFABUTIN 150 MG CAPSULE?

Since May 17, 2023, the NADAC for RIFABUTIN 150 MG CAPSULE has ranged from a low of $7.3273 (Jun 19, 2024) to a high of $10.7596 (Jun 14, 2023), with a median of $9.3240 per EA.

Are there cheaper alternatives to RIFABUTIN 150 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of RIFABUTIN 150 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures RIFABUTIN 150 MG CAPSULE?

RIFABUTIN 150 MG CAPSULE (NDC 70954004110) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.